EMBLEM™ MRI S-ICD System

Access EDUCARE image
S-ICD Best Practices Guide
Created in collaboration with leading physicians and clinical experts, this Best Practices guide covers the best practices on S-ICD implant technique from preparation, to system placement, defibrillation testing, and replacements.

Key Resources

Directions for Use Patient Selection Tool S-ICD Patient Website Indications, Safety & Warnings
SIGN UP FOR NEWSLETTER
icon-educare-cta.png

Learn on EDUCARE

S-ICD as a First-Line Therapy:
Results from the PRAETORIAN and UNTOUCHED Trials

Emblem S-ICD
S-ICD as a First-Line Therapy​ | Part 1 of 3​

 

Results from the PRAETORIAN Trial​
Presented by Dr Reinoud Knops, Academic Medical Center, Amsterdam​
Moderated by Dr Ulrika Birgersdotter-Green, University of California, San Diego​

Emblem S-ICD
S-ICD as a First-Line Therapy​ | Part 2 of 3​

 

Results from the UNTOUCHED Trial ​
Presented by Dr Michael Gold, Medical University of South Carolina ​
Moderated by Dr Ulrika Birgersdotter-Green, University of California, San Diego ​

Emblem S-ICD
S-ICD as a First-Line Therapy​ | Part 3 of 3​

 

Results from the PRAETORIAN and UNTOUCHED Trials Q&A​
Presenters:​
Dr Reinoud Knops, Academic Medical Center, Amsterdam​
Dr Michael Gold, Medical University of South Carolina​
Moderated by Dr Ulrika Birgersdotter-Green, University of California, San Diego​

Emblem S-ICD
Dr. Roser discusses the actual need for ATP

 

Past and Current Perceptions of the clinical need for ATP. Dr. Roser discusses Selecting the right therapy for the right patient. Are we treating patients according to their indications today?

Lindsay sharing insights
Lindsay sharing insights on Patient Involvement

 

A growing Patients Role in today’s Healthcare: Prof. John Morgan and S-ICD patient Lindsay Davis discuss the psychological and clinical impact of an ICD implant and important pre-implant considerations.

Dr. Botto highlights AIAC Survey Results

 

The Italian subcutaneous implantable cardioverter-defibrillator survey: “S-ICD, why not?” showed that 89% of all ICD-indicated patients were eligible to receive an S-ICD.1

Download the full publication here
Dr. Theuns summarizes the main conclusions

 

Dr. Theuns was chairing the S-ICD symposium at Cardiostim: Advanced and Less Invasive Approaches for Sudden Death Prevention in the Era of Personalized Medicine.

Experts discuss the ESC guidelines

 

Dr. Steffel, Dr. Botto, Prof. Morgan, Prof. Probst, Prof. Zamorano and Prof. Hatala share their view on the importance of implementing the new ESC Guidelines, with the inclusion of Subcutaneous ICD’s.  

Dr. Boersma discusses EFFORTLESS

 

3-Yrs of follow-up in ~1000 patients demonstrates S-ICD safety & efficacy is comparable to TV-ICDs while avoiding the serious complications associated with having a lead in the heart.


 
Top